Fingerprint
Dive into the research topics of 'A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia
Peter J. Rosen, Cathryn Rankin, David R. Head, David H. Boldt, Frederick W. Luthardt, Thomas Norwood, Reginald P. Pugh, Chatchada Karanes, Frederick R. Appelbaum
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations